(Q36978875)

17 August 2017

4 references

25 April 2019

2 October 2019

7 November 2019

21 January 2024

Parenteral vs. oral sumatriptan and naratriptan: plasma levels and efficacy in migraine. a comment (English)

1 reference

Peer Carsten Tfelt-Hansen

17 August 2017

3 references

25 April 2019

2 October 2019

7 November 2019

1 reference

2 October 2019

1 reference

7 November 2019

1 reference

7 November 2019

series ordinal

1

object named as

Peer Tfelt-Hansen

1 reference

17 August 2017

23 October 2007

1 reference

PMC publication ID

3476154

The journal of headache and pain : official journal of the Italian Society for the Study of Headaches

17 August 2017

1 October 2007

4 references

25 April 2019

2 October 2019

7 November 2019

21 January 2024

5 references

17 August 2017

25 April 2019

2 October 2019

7 November 2019

21 January 2024

8

1 reference

17 August 2017

5

1 reference

17 August 2017

273-276

1 reference

The discovery of a new drug class for the acute treatment of migraine

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3476154

Pharmacokinetics of sumatriptan in non-respondent and in adverse drug reaction reporting migraine patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3476154

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3476154

Pharmacokinetics and pharmacodynamics of the triptan antimigraine agents: a comparative review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3476154

Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3476154

Efficacy of naratriptan tablets in the acute treatment of migraine: a dose-ranging study. Naratriptan S2WB2004 Study Group

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3476154

Early clinical experience with subcutaneous naratriptan in the acute treatment of migraine: a dose-ranging study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3476154

Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, parallel-group study. Naratriptan S2WA3001 Study Group

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3476154

Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, crossover study. The Naratriptan S2WA3003 Study Group

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3476154

Pharmacokinetic and pharmacodynamic profiles of sumatriptan in migraine patients with headache recurrence or no response.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3476154

Sumatriptan for the treatment of migraine attacks--a review of controlled clinical trials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3476154

Dose ranging efficacy and safety of subcutaneous sumatriptan in the acute treatment of migraine. US Sumatriptan Research Group

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3476154

Naratriptan: biological profile in animal models relevant to migraine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3476154

Treatment of migraine attacks with subcutaneous sumatriptan: first placebo-controlled study. The Subcutaneous Sumatriptan International Study Group

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3476154

Maximum effect of triptans in migraine? A comment

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3476154

311C90 (Zolmitriptan), a novel centrally and peripheral acting oral 5-hydroxytryptamine-1D agonist: a comparison of its absorption during a migraine attack and in a migraine-free period.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3476154

Treatment of Acute Cluster Headache with Sumatriptan

4 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10194-007-0411-X

Single dose pharmacokinetics of sumatriptan in healthy volunteers

21 January 2018

1 reference

12 December 2020

Guidelines for controlled trials of drugs in migraine: second edition

1 reference

12 December 2020

Absorption of effervescent aspirin during migraine

1 reference

12 December 2020

Sumatriptan--an oral dose-defining study. The Oral Sumatriptan Dose-Defining Study Group

1 reference

12 December 2020

10.1007/S10194-007-0411-X

Identifiers

DOI

1 reference

17 August 2017

1 reference

PMC publication ID

3476154

17 August 2017

PubMed publication ID

17955173

1 reference

PMC publication ID

3476154